Literature DB >> 32935166

Assessment of ability of human adipose derived stem cells for long term overexpression of IL-11 and IL-13 as therapeutic cytokines.

Asma Eslami1, Moein Dehbashi2, Mehnoosh Ashja-Arvan1, Hossein Salehi3, Maryam Azimzadeh3, Mazdak Ganjalikhani-Hakemi4.   

Abstract

Adipose-derived stem cells (ADSCs) are a type of mesenchymal stem cells with the therapeutic effects that make them one of the best sources for cell therapy. In this study, we aimed to assess the ability of human ADSCs for constant expression of IL-11 and IL-13, simultaneously. In this study, the characterized hADSCs were transduced with a lentiviral vector (PCDH-513B) containing IL-11 and IL-13 genes, and the ability of long-term expression of the transgenes was evaluated by ELISA technique on days 15, 45 and 75 after transduction. Our results indicated a high rate of transduction (more than 90%) in the isolated hADSCs. Our data showed the highest rate of expression on days 75 after transduction which was 242.67 pg/ml for IL-11 and 303.6 pg/ml for IL-13 compared with 35.2 pg/ml and 35.6 pg/ml in untreated cells, respectively (p = 0.001). Besides, MTT assay showed transduction of hADSCs with lentiviral viruses containing IL-11 and IL-13 had no adverse effect on hADSCs proliferation (p-value = 0.89). Finally, we successfully constructed a hADSC population stably overexpressing IL-11 as the neurotrophic cytokine and IL-13 as the anti-inflammatory cytokine and this transduced cells can be used for further studies in EAE mice model.

Entities:  

Keywords:  Human adipose derived stem cell (hADSC); Interleukin11; Interleukin13; Lentiviral vector; Overexpression

Year:  2020        PMID: 32935166      PMCID: PMC7547926          DOI: 10.1007/s10616-020-00421-8

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  41 in total

1.  A stable system for the high-titer production of multiply attenuated lentiviral vectors.

Authors:  N Klages; R Zufferey; D Trono
Journal:  Mol Ther       Date:  2000-08       Impact factor: 11.454

2.  Isolation, culture and identification of human adipose-derived stem cells.

Authors:  Jian-Mei Wang; Yan Gu; Cai-Jun Pan; Li-Rong Yin
Journal:  Exp Ther Med       Date:  2017-01-20       Impact factor: 2.447

3.  Lentiviral-transduced human mesenchymal stem cells persistently express therapeutic levels of enzyme in a xenotransplantation model of human disease.

Authors:  Todd E Meyerrose; Marie Roberts; Kevin K Ohlemiller; Carole A Vogler; Louisa Wirthlin; Jan A Nolta; Mark S Sands
Journal:  Stem Cells       Date:  2008-04-24       Impact factor: 6.277

4.  Early intervention with gene-modified mesenchymal stem cells overexpressing interleukin-4 enhances anti-inflammatory responses and functional recovery in experimental autoimmune demyelination.

Authors:  Natalie L Payne; Ashanti Dantanarayana; Guizhi Sun; Leon Moussa; Sally Caine; Courtney McDonald; Daniella Herszfeld; Claude C A Bernard; Christopher Siatskas
Journal:  Cell Adh Migr       Date:  2012-05-01       Impact factor: 3.405

5.  Neuroimmunology of the Interleukins 13 and 4.

Authors:  Simone Mori; Pamela Maher; Bruno Conti
Journal:  Brain Sci       Date:  2016-06-13

6.  Cell-Based Delivery of Interleukin-13 Directs Alternative Activation of Macrophages Resulting in Improved Functional Outcome after Spinal Cord Injury.

Authors:  Dearbhaile Dooley; Evi Lemmens; Tim Vangansewinkel; Debbie Le Blon; Chloé Hoornaert; Peter Ponsaerts; Sven Hendrix
Journal:  Stem Cell Reports       Date:  2016-12-13       Impact factor: 7.765

Review 7.  Molecular mechanisms of oligodendrocyte injury in multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Jilpa Patel; Roumen Balabanov
Journal:  Int J Mol Sci       Date:  2012-08-23       Impact factor: 6.208

8.  Pharmaceutical integrated stress response enhancement protects oligodendrocytes and provides a potential multiple sclerosis therapeutic.

Authors:  Sharon W Way; Joseph R Podojil; Benjamin L Clayton; Anita Zaremba; Tassie L Collins; Rejani B Kunjamma; Andrew P Robinson; Pedro Brugarolas; Robert H Miller; Stephen D Miller; Brian Popko
Journal:  Nat Commun       Date:  2015-03-13       Impact factor: 14.919

9.  The Human IL-23 Decoy Receptor Inhibits T-Cells Producing IL-17 by Genetically Engineered Mesenchymal Stem Cells.

Authors:  Masoumeh Rostami; Kamran Haidari; Majid Shahbazi
Journal:  Int J Cell Biol       Date:  2018-12-19

10.  Peripheral Administration of IL-13 Induces Anti-inflammatory Microglial/Macrophage Responses and Provides Neuroprotection in Ischemic Stroke.

Authors:  Natalia Kolosowska; Meike H Keuters; Sara Wojciechowski; Velta Keksa-Goldsteine; Mika Laine; Tarja Malm; Gundars Goldsteins; Jari Koistinaho; Hiramani Dhungana
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.